American Society of Clinical Oncology clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

   Trial sites expanded: 83 → 88 locations

   And 1 more change in the last 30 days

   American Society of Clinical Oncology·Phase 3· NCT06377852· Registry history of NCT06377852 on ClinicalTrials.gov (opens the registry)

   Oct 6, 2026

2. Minor

   TAPUR · Use of Food and Drug Administration (FDA) Approved Drugs…TAPUR · Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene · Advanced Stage Cancer

   Interventions modified

   Also in this update: Trial arms changed: 13 → 12

   American Society of Clinical Oncology·Phase 2· NCT02693535· Registry history of NCT02693535 on ClinicalTrials.gov (opens the registry)

   Sep 22, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.